Kronos Bioの空売り状況は、投資家がKronos Bioの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Kronos Bio (NASDAQ:KRON) 株価情報, 空売り情報

Kronos Bio

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Kronos Bio Inc

Krones AG

KRONOS ADVANCED TECHS INC by Kronos Advanced Technologies, Inc.

Kronos Advanced Technologies Inc

Kronos Worldwide Inc

Canada has started preparing for potential retaliatory tariffs on U.S. goods following President-elect Donald Trump's recent threats to impose sweeping <a href="https://www.benzinga.com/topic/canada">duties on Canadian imports.</a> 
A senior Canadian government official told <a href="https://apnews.com/article/canada-trump-tariffs-trudeau-c741393c2f7c7545e9714839cfbbda45">AP News</a> Wednesday that discussions are underway to target certain U.S. items if Trump follows through on his proposed 25% tariff, although no final decision has been made.
This move comes as Trump renews his hardline stance on trade, calling for punitive tariffs to address what he described as the flow of drugs and migrants across both the northern and southern borders. 
Canada has faced a similar situation in the past, such as in 2018 when it imposed billions of dollars in retaliatory duties on U.S. goods after the Trump administration hiked tariffs on Canadian steel and aluminum.
<h3 class="wp-block-heading">Canadian Dollar Poised For Further Declines</h3>
Wall Street analysts expect additional downside in the Canadian dollar – as tracked by the Invesco CurrencyShares Canadian Dollar Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXC#NYSE">FXC</a>) – if the tariff threats materialize.
Robert Kavcic, senior economist at BMO Economics, highlighted Canada's vulnerability as a &#8220;small, open economy&#8221; heavily reliant on U.S. trade. 
&#8220;The U.S. market accounts for roughly 75% of Canadian goods exports, which in total comprise about 25% of Canadian GDP,&#8221; Kavcic wrote in a note.
"In general, we'd expect the Canadian dollar to see the biggest and most immediate market impact, extending the weakness seen in recent months. In this event, we see room for further depreciation from recent levels above 1.41 against the dollar."
Shaun Osborne, chief forex strategist at Scotiabank, also expressed skepticism about Canada's ability to quickly address the incoming administration&#8217;s concerns. 
Osborne explained that Trump's newly appointed &#8220;border czar,&#8221; Tom Homan, has already labeled the northern border as &#8220;an extreme national security issue,&#8221; which could complicate negotiations.
&#8220;More CAD losses seem inevitable unless the Canadian government can muster a response that satisfies the incoming administration quickly, however. That may not be easy,&#8221; Osborne warned. 
He continued, &#8220;The risk of 25% tariffs remains just that at the moment, but the longer the threat lingers and the closer we get to the inauguration, the weaker the CAD may trade."
According to data from the U.S. Census Bureau, U.S. imports from Canada reached $481 billion in 2023, while Canadian imports of U.S. goods amounted to $354 billion during the same period.
In terms of products, Canada's top export to the United States was crude oil and other fuels, totaling approximately $120 billion, followed by vehicles at $58 billion.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42219612/usmexico-trade-tensions-escalate-as-mexican-peso-hits-august-2022-lows-why-is-auto-industry-most-at-risk">US–Mexico Trade Tensions Escalate As Mexican Peso Hits August 2022 Lows: Why Is Auto Industry Most At Risk?</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Government

Macro Economic Events

Regulations

Currency ETFs

Politics

Forex

Global

Economics

Markets

Analyst Ratings

ETFs

Canada Prepares Retaliatory Tariffs After Trump Threats: Analysts Warn Of Further Loonie Weakness

Mexican President Claudia Sheinbaum responded to U.S. President-elect Donald Trump in a letter published Tuesday, addressing the issue of the <a href="https://www.benzinga.com/markets/cannabis/24/03/37445551/overdose-crisis-worsens-the-rise-of-fentanyl-smoking-leads-to-even-more-deaths-than-shooting-her">fentanyl crisis</a> and broader drug-related challenges.
Her message emphasized cooperation over confrontation — whereas Trump has a <a href="https://www.benzinga.com/news/24/10/41563454/trumps-escalating-threats-to-rivals-100-and-counting">penchant for the latter</a>.
&#8220;Neither threats nor tariffs will solve the migration or the drug abuse phenomenon in the US,&#8221; Sheinbaum <a href="https://x.com/Claudiashein/status/1861558804652999130">said</a>, calling for collaborative solutions to mitigate the escalating drug crisis.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Migración y consumo de fentanilo no se atenderán con amenazas ni aranceles. México avanza con resultados en acciones integrales; la cooperación y el entendimiento son necesarios. El diálogo es el camino. <a href="https://t.co/mwXkhUCwbL">pic.twitter.com/mwXkhUCwbL</a>
&mdash; Claudia Sheinbaum Pardo (@Claudiashein) <a href="https://twitter.com/Claudiashein/status/1861558804652999130?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Sheinbaum To Trump: Fentanyl &#8216;Is An Issue In Your Country&#8217; </h3>
&#8220;For humanitarian reasons, we have consistently expressed Mexico&#8217;s commitment to preventing the continuation of the <a href="https://www.benzinga.com/general/health-care/24/11/42146502/us-overdose-deaths-decline-as-fentanyl-potency-weakens-harm-reduction-expands">fentanyl epidemic</a> in the United States, which, moreover, is an issue of consumption and public health in your country,&#8221; Sheinbaum says in the letter, which she read during her usual morning conferences. 
Sheinbaum detailed Mexico's recent measures, including enforcement actions by the armed forces and prosecutors. According to the data she shared, in 2024 alone, authorities seized large quantities of &#8220;various drugs&#8221;, confiscated over 10,340 firearms, and arrested more than 15,640 individuals for drug-related violence.
Furthermore, she noted Mexico&#8217;s legislative progress toward stricter penalties.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Not Us</h3>
Sheinbaum called attention to the illicit flow of chemical precursors from Asia, which enter North America through Canada, the U.S., and Mexico. 
She stressed that addressing this issue requires international collaboration: &#8220;It is publicly known that these precursors are smuggled into North America. This makes global cooperation imperative.&#8221;
The president juxtaposed the flow of drugs with the southbound<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42166673/drug-cartels-use-tether-and-bitcoin-to-launder-millions-court-documents-reveal"> illegal trafficking</a> of <a href="https://www.benzinga.com/topic/guns">firearms</a> from the U.S. into Mexico. 
She cited stark statistics: 70% of illegal weapons seized in Mexico originate in the U.S., fueling violence. 
&#8220;The synthetic drugs are not consumed by us, and the weapons are not produced here. Yet, we bear the brunt of the deaths caused by organized crime in response to the demand for drugs in your country.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says">How Trump&#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says</a>
<h3 class="wp-block-heading">&#8216;Reciprocal Understanding And Cooperation&#8217;</h3>
Sheinbaum rejected the efficacy of punitive tariffs in addressing these challenges. 
Instead, she urged for &#8220;reciprocal understanding and cooperation&#8221; between the two nations. 
She noted that mutual economic ties, especially in industries like automotive manufacturing, <a href="https://www.benzinga.com/news/global/24/11/42198583/will-trump-lead-us-into-trade-war-with-mexico-president-claudia-sheinbaum-rebukes-threats">would suffer</a> under an antagonistic approach, leading to inflation and job losses on both sides of the border, and posed that both Mexico and the U.S. should work together on a mobility program instead of reinforcing the borders. 
&#8220;I am convinced that North America's economic strength lies in preserving our commercial partnership. Dialogue is the best path toward understanding, peace, and prosperity for our nations,&#8221; she added.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42202496/goldman-sachs-expects-major-selloffs-in-canadian-dollar-mexican-peso-says-trump-tariffs-threaten-usmca-agreement"> Goldman Sachs Expects Major Selloffs In Canadian Dollar, Mexican Peso, Says Trump Tariffs Threaten USMCA Agreement</a></li>
</ul>
Translations in this article were made by Rolando García
Cover: Shutterstock.

Cannabis

News

Mexico President Claudia Sheinbaum To Trump: 'Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares have been treading water for the better part of the past month. The company reported earnings at the end of October. Here&#8217;s a look at what <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">you need to know</a>.
What To Know: Meta shares have struggled to move higher since the company reported third-quarter financial results last month. Although Meta <a href="https://www.benzinga.com/news/earnings/24/10/41637326/meta-platforms-q3-earnings-revenue-beat-eps-beat-daily-actives-up-5-strong-momentum-in-ai">beat analyst estimates</a> on the top and bottom lines as revenue jumped 19% and daily actives climbed 5%, the stock faced selling pressure due to spending concerns. 
Meta raised its full-year 2024 capital expenditures&nbsp;outlook by $1 billion and said it continues to expect operating losses to &#8220;increase meaningfully&#8221; year-over-year&nbsp;for Reality Labs.
It&#8217;s worth noting that insiders have been selling Meta shares in recent months. CEO Mark Zuckerberg, CFO Susan Li and COO Javier Olivan all sold shares in November under trading plans, with Olivan most recently selling shares on Monday, according to Benzinga <a href="https://www.benzinga.com/quote/META/insider-trades">data</a>.
On a positive note, <a href="https://www.axios.com/2024/11/26/exclusive-threads-adds-35m-new-signups-this-month">Axios</a> reported Wednesday that Meta&#8217;s Threads has added 35 million new users on the platform since Nov. 1. Micro-blogging startup Bluesky has seen users flock to the platform since Election Day, suggesting users are leaving X because of Elon Musk&#8217;s political views. Meta also appears to be a beneficiary.
Check This Out: <a href="https://www.benzinga.com/24/11/42193222/orange-taps-openai-meta-to-create-ai-that-speaks-african-languages">Meta, OpenAI, Orange Join Forces To Build AI Models For African Languages</a>
On the earnings call last month, Zuckerberg said Threads had over 275 million monthly active users. That number appears to be growing rapidly with Axios reporting that the app has seen more than one million daily sign-ups for three months straight.
Meta aims to capitalize on the momentum. Zuckerberg on Monday said Threads is testing a new feature that will allow users to choose what they see when they open the app. Previously, Threads directed users to a default feed, but users can now choose to only see posts from accounts they follow.
Meta is also set to <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">head to trial in April</a> after Judge James Boasberg rejected Meta&#8217;s attempted dismissal of the case and set a court date earlier this week. The Facebook parent company will face U.S. Federal Trade Commission allegations that it acquired Instagram and WhatsApp&nbsp;to stifle competition in the social media space. 
META Price Action: Meta shares closed Wednesday down 0.76% at $569.20, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

What's Up With Meta Stock Lately?

The cryptocurrency <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">XRP Token</a> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) from Ripple has soared in price over the last week, with optimism coming from an XRP exchange-traded fund and news that Ripple will invest in a newly rebranded <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42220218/ripple-to-invest-in-rebranded-xrp-exchange-traded-product-by-bitwise">Physical XRP ETP.</a>
While Ripple has hit new 52-week highs, the cryptocurrency remains down from all-time highs.
What Happened: Asset manager WisdomTree recently filed to establish a trust that could lead to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42170669/wisdomtree-files-for-xrp-etf-trust-report">launch of an XRP ETF.</a>
This move follows others like Bitwise who have already filed to launch similar ETFs. On Wednesday, Ripple announced it would invest in the new rebranded Bitwise Physical XRP ETP.
&#8220;Global demand for exposure to the crypto asset class has exploded in 2024,&#8221; Ripple CEO Brad Garlinghouse said in a&nbsp;<a href="https://www.globenewswire.com/news-release/2024/11/27/2987978/0/en/Bitwise-Rebrands-XRP-ETP-Ripple-To-Invest-in-Product.html" target="_blank" rel="noreferrer noopener">statement</a>. &#8220;XRP is at the forefront of this momentum, standing out as a cornerstone for those seeking access to assets that are resilient and have real-world utility.&#8221;
Bitwise CEO Hunter Horsley said XRP's utility and reliability are among the reasons investors are excited about XRP.
&#8220;XRP and the XRP Ledger are among the most familiar and trusted blockchains in crypto," Horsley said.
With Bitcoin and Ethereum ETFs already approved, cryptocurrency experts see ETFs based on other top 10 cryptos by market capitalization like Solana, Dogecoin and XRP as the&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011875/solana-ripple-litecoin-etfs-may-be-on-the-table-under-trump-administration-industry-experts-think" target="_blank" rel="noreferrer noopener">next to be approved.</a>
The XRP token has gone through many wild swings over the years, with a case brought on by the SEC alleging XRP to be a security, sending the price and interest in the cryptocurrency down. A landmark court ruling that said XRP was not a security helped bring the cryptocurrency&#8217;s price back up.
While XRP has risen in value in recent months, the cryptocurrency remains down from all-time highs.
Read Also: <a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a>
Investing $100 in XRP Today: XRP trades at $1.51 at the time of writing, up 9% over the last 24 hours.
A $100 investment today could purchase 66.2252 XRP.
XRP hit an all-time high of $3.84 on June 4, 2018.
If XRP returns to its 2018 all-time high of $3.84, the $100 investment would be worth $254.30. This represents a potential gain of 154.3%.
There is no guarantee that the XRP Token will return to its all-time highs.
The hypothetical investment shows that a small investment could gain over time if the cryptocurrency market returns to its high mark.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41908812/if-you-invested-100-in-dogecoin-when-the-meme-coin-launched-heres-how-much-youd-have-today">If You Invested $100 In Dogecoin When The Meme Coin Launched, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$XRP

Here's How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs

Offerings

Cyngn Files For Offering Of Up To 3.06M Units, Up To 3.06M Pre-Funded Units

APLT

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

CTHR

Charles & Colvard Receives Nasdaq Notice About Non-Compliance Of Listing Rule 5250(c)(1)

Velocity Financial Files For Stock Shelf Of Up To $100M

MRKR

Marker Therapeutics Sales Agreement Prospectus Covers Offering Of Up To $11.4M Of Common Stock That May Be Issued From Time To Time

Converium Capital and Erez Asset Management will vote their shares in favor of all of the Board's director nominees at the 2025 Annual Meeting of Stockholders. Under the Cooperation Agreement, Converium Capital and Erez Asset Management have agreed to customary standstill, voting and other provisions.&nbsp;

Management

Franklin Street Properties Enters Cooperation Agreement With Shareholders Converium Capital And Erez Asset Management; Adds Bruce Schanzer To Board

Marker Therapeutics Files For Mixed Shelf Of Up To $300M

Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares traded higher on Wednesday following the release of the company&#8217;s third-quarter earnings report, which exceeded expectations. Here&#8217;s <a href="https://www.benzinga.com/quote/URBN/news">what you need to know.</a>
What To Know: Urban Outfitters reported third-quarter earnings per share of $1.10, beating estimates of 89 cents. Revenue came in at $1.36 billion, up 6.3% year-over-year and ahead of the consensus estimate of $1.32 billion.
The company posted net income of $102.9 million for the quarter, compared to $83 million a year ago. Retail net sales rose 3.2%, with comparable retail sales up 1.5%. Anthropologie and Free People brands reported comparable sales growth of 5.8% and 5.3%, respectively, while Urban Outfitters brand sales fell 8.9%.
See More: <a href="https://www.benzinga.com/24/11/42221225/these-analysts-increase-their-forecasts-on-urban-outfitters-after-q3-results">These Analysts Increase Their Forecasts On Urban Outfitters After Q3 Results</a>
Nuuly, the company's subscription rental service, grew sales by 48.4%, supported by a 51% increase in active subscribers. Wholesale revenue increased 17.4%, driven by a 20.3% rise in Free People wholesale sales, partially offset by declining Urban Outfitters wholesale revenue.
Gross profit for the quarter rose 9.4% to $497.3 million, with a 105-basis-point improvement in gross margin due to higher merchandise markups and fewer markdowns at Urban Outfitters. Operating expenses increased 6.7%, reflecting higher marketing and store payroll costs.
&#8220;These results were driven by outperformance across all three business segments – Retail, Subscription and Wholesale. Additionally, we&#8217;re optimistic about the outlook for Holiday demand and believe total comparable sales could be similar to our third quarter results,&#8221; said Richard Hayne, CEO of Urban Outfitters.
The company ended the quarter with $182.5 million in cash, $340.4 million in marketable securities and a 10% inventory increase, largely due to early holiday merchandise shipments and higher sales expectations.
Following the print, several analysts raised price targets, which appears to have helped push shares higher on Wednesday.
<ul>
<li>Citigroup analyst Paul Lejuez upgraded Urban Outfitters from Neutral to Buy and raised the price target from $42 to $59.</li>
</ul>
<ul>
<li>Telsey Advisory Group analyst Dana Telsey maintained a Market Perform and raised the price target from $44 to $46.</li>
</ul>
<ul>
<li>BofA Securities analyst Lorraine Hutchinson maintained a Buy and raised the price target from $46 to $53.</li>
</ul>
<ul>
<li>Barclays analyst Adrienne Yih maintained an Overweight and raised the price target from $43 to $51.</li>
</ul>
<ul>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight and raised the price target from $40 to $48.</li>
</ul>
URBN Price Action: Urban Outfitters shares closed Wednesday up 18.3% at $47.49, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="521" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-1024x521.png" alt="" class="wp-image-668199" style="width:474px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN.png 1465w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/travel/24/11/42223099/boeing-faces-heat-from-frustrated-emirates-over-52-billion-aircraft-delays">Boeing Faces Heat From &#8216;Frustrated&#8217; Emirates Over $52 Billion Aircraft Delays</a></li>
</ul>
Image Via Shutterstock.

Earnings

Price Target

URBN

Urban Outfitters Stock Surged Wednesday: What Happened?

GYRE

Gyre Therapeutics Entered Into Open Market Sale Agreement, May Offer & Sell Shares Of Common Stock Of Up To $50M From Time To Time

Cryptocurrency Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is seeing a sharp rise in valuation in recent days, which comes as other cryptocurrencies like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) have hit all-time highs since <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41778425/bitcoins-all-time-high-a-groundbreaking-milestone-and-strong-post-election-rally-coming-ex">the 2024 election.</a>
While Ethereum has gained less than Bitcoin in 2024 and trades below its all-time highs set in 2015, investors who bought the cryptocurrency years ago are still profitable on their trades. &nbsp;
What Happened: Ethereum co-founder Vitalik Buterin proposed Ethereum in 2014<a href="https://www.benzinga.com/markets/cryptocurrency/21/09/22811912/5-things-you-might-not-know-about-ethereum-creator-vitalik-buterin-3"> via a white paper.</a> The cryptocurrency <a href="https://www.benzinga.com/24/11/42125090/if-you-invested-1000-in-ethereum-at-launch-heres-how-much-youd-have-today">officially launched</a> in 2015 and has been one of the most well-known and valuable cryptocurrencies since that time.
Many well-known cryptocurrencies had impressive runs in 2021. Ethereum was a big gainer in 2021 going from $737.71 to $3,682.63.
One of the factors that helped Ethereum in 2021 was increased interest and massive valuations for non-fungible tokens.
Larva Labs launched CryptoPunks on June 23, 2017. The collection of 10,000 24&#215;24 pixel art images built on the Ethereum blockchain is now one of the biggest non-fungible token collections.
One of the early NFT launches, CryptoPunks are highly coveted among NFT collectors and often times serve as profile pictures for those in the cryptocurrency community on social media.
The project was not an early success but has quickly become the standard among NFT collections attracting investments from celebrities and investors alike.
While many NFT collections have witnessed drops in their price and lack of interest from investors, CryptoPunks are one of the few that have held up in value and demand. The collection is seeing recent interest with over $10.75 million in sales in the last week.
The floor <a href="https://cryptopunks.app/">price </a>for a CryptoPunks NFT, or lowest price to buy one, is currently 37.24 ETH, or around $133,695 at the time of writing.
Although Ethereum's price has declined since 2021, investing during the historic NFT launch would still have yielded a profit.
Read Also: <a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a>
Investing $1,000 in ETH:&nbsp;At the time of the CryptoPunks launch, Ethereum hit a high of $348.01.
A $1,000 investment in Ethereum on this historic day could have bought 2.8735 ETH.&nbsp;That investment from 2017 would be worth $10,361.81 today based on a price of $3,605.99 at the time of writing.
The investment would be up 936.2% in the last seven-plus years.
Ethereum hit one-month highs of $3,614.88 on Nov. 27. The cryptocurrency has traded between $2,020.76 and $4,092.28 over the last year, hitting highs in March around the time Ethereum ETFs were approved by the SEC. The all-time high for Ethereum is $4,891.70, hit in November 2021. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42125880/if-you-bought-1-worth-of-bitcoin-at-launch-heres-how-much-youd-have-today-2">If You Bought $1 Worth Of Bitcoin At Launch, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

$BTC

$ETH

If You Invested $1,000 In Ethereum When CryptoPunks Were Released, Here's How Much You'd Have Now

Digital Ally, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) (the "Company") today announced it received a delinquency notification letter from Nasdaq on November 25, 2024, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Quarterly Report"). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC"). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
Nasdaq has informed the Company that it must submit a plan to regain compliance with respect to the filing requirement by January 24, 2025. If the plan is accepted, Nasdaq can grant an exception of up to 180 calendar dates from the due date of the initial delinquent filing for the period ended September 30, 2024, or until May 19, 2025, to regain compliance.
The Company is working diligently to file the Quarterly Report as promptly as practical, and expects to return to a normal filing cadence in 2025.

DGLY

Digital Ally Receives Notification Of Deficiency From Nasdaq

This notification has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market.
 &nbsp;

UGRO

urban-gro Gets Nasdaq Notification Of Non-Compliance With Listing Rule 5250(c)(1)

Wall Street eyes 2025 with confidence as JPMorgan declares the <a href="https://www.benzinga.com/trading-ideas/long-ideas">U.S. will remain</a> the global growth leader.
While Europe wrestles with structural woes, the emerging markets face headwinds from high interest rates and a strong dollar. Meanwhile, the U.S. is powering ahead, fueled by an AI-driven spending spree and robust capital market activity.
<h1 class="wp-block-heading">AI Spending: A $1 Trillion Juggernaut</h1>
Artificial intelligence is sparking a capital expenditure boom that dwarfs anything seen in decades. The Magnificent 7 — Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) — plan to invest over $500 billion into capex and R&amp;D next year, roughly 25% of their combined sales.
JPMorgan estimates the broader AI ecosystem could surpass $1 trillion in spending by the end of the year. This includes costs for infrastructure, engineering talent and data center upkeep.
While this AI frenzy promises to drive earnings growth, JPMorgan analysts warn of potential pitfalls. Capital misallocation and lofty growth expectations could draw investor skepticism by late 2025. 
Still, the long-term AI opportunity is undeniable, and JPMorgan sees key players poised to capitalize.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42137929/2025-us-economy-outlook-cloudier-than-normal-jpmorgan-says-boom-bust-scenarios">2025 US Economy Outlook &#8216;Cloudier Than Normal,&#8217; JPMorgan Says: Boom, Bust Scenarios</a>
<h1 class="wp-block-heading">A Broad Earnings Recovery</h1>
JPMorgan projects a bounce-back year for earnings growth in 2025. S&amp;P 500 companies are projected to achieve an 11.4% earnings increase with all 11 sectors turning positive after 2024&#8217;s uneven performance.
Meanwhile, small-cap Russell 2000 firms should see rebounding with double-digit earnings growth after enduring two years of declines.
Even the Magnificent 7 are expected to sustain a 15% growth rate.
JPMorgan analysts note a surprising upside could emerge if borrowing costs or the U.S. dollar ease. This should boost S&amp;P 500 earnings by 1% for every 2% drop in the dollar.
<h1 class="wp-block-heading">Stock Picks: Who's In JPMorgan's Cart?</h1>
Here are a few of the top picks per theme, from JPMorgan&#8217;s 2025 outlook, which the firm has an Overweight (OW) rating on:
<ul>
<li>AI Winners: Amazon, Microsoft, Nvidia, Alphabet, Meta, Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>).</li>
<li>Deregulation Darlings: Apple, ExxonMobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Baker Hughes Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>).</li>
<li>America First Beneficiaries: Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), Caterpillar Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>), and more.</li>
</ul>
With an AI boom, a broad earnings recovery, and pro-American policies potentially reshaping the landscape, JPMorgan's 2025 vision sets a bold tone for the year ahead. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42222736/jpmorgans-volatility-play-long-vix-calls-short-spy-puts">JPMorgan&#8217;s Volatility Play: Long VIX Calls, Short SPY Puts</a></li>
</ul>
Photo: Sutthiphong Chandaeng via Shutterstock

Long Ideas

Tech

Trading Ideas

AAPL

AMZN

GOOG

GOOGL

MSFT

NVDA

QCOM

TSLA

2025 Stock Playbook: Tap Into AI's $1 Trillion Potential, US Growth Opportunities

ATMV

Alphavest Acquisition To Begin Trading On Nasdaq Capital Market On November 14, 2024

Mach Natural Resources LP Files For Mixed Shelf Of $300M

ONMD

OneMedNet Reveals Receipt Of Nasdaq Notice About Non-Compliance Regarding Delayed Form 10-Q

Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The company's shares c...

TD Cowen downgrades Kronos Bio (KRON) to a Hold

Piper Sandler last night downgraded Kronos Bio (KRON) to Neutral from Overweight with a price target of $1, down from $6. The company is discontinu...

Piper downgrades Kronos Bio on istisociclib discontinuation

TD Cowen downgraded Kronos Bio (KRON) to Hold from Buy without a price target after the company announced the decision to halt clinical development...

Kronos Bio downgraded to Hold from Buy at TD Cowen

Kronos Bio downgraded by Piper Sandler, TD Cowen

Kronos Bio (KRON) highlighted preclinical data from its p300 KAT inhibitor program for autoimmune indications at the American College of Rheumatolo...

Kronos Bio to present preclinical data from p300 KAT inhibitor program

The company said, "As announced on November 13, 2024, Kronos Bio (KRON) is exploring strategic alternatives for the Company and its remaining inter...

Kronos Bio provides update on review of strategic alternatives

The latest update is out from Kronos Bio ( ($KRON) ). Kronos Bio, Inc. is undergoing a significant transformation with an 83% workforce reduction a...

Kronos Bio Restructures Workforce and Leadership

Kronos Bio (KRON) announced that its Board of Directors has appointed Deborah Knobelman, Ph.D., as President and Inteim CEO, effective December 3, ...

Kronos Bio CEO Norbert Bischofberger steps down, Deborah Knobelman named interim

The company announced a workforce reduction of approximately 83 percent by year end as part of its previously announced plan to implement cost redu...

Kronos Bio announces workforce reduction of 83% by year-end

Kronos Bio announces interim CEO; over 80% of staff reduction

KRON

Health Care

Press Releases

Kronos Bio Announces Participation in Medical and Investor Conferences in September

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

General

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren's Disease

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

Comments

Kronos Bio

空売り

Kronos Bio (NASDAQ:KRON) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル